Development of a RP-HPLC method for analysis of docetaxel in tumor-bearing mice plasma and tissues following injection of docetaxel-loaded pH responsive targeting polymeric micelles

Moloud Kazemi , Jaber Emami , Farshid Hasanzadeh, Mohsen Minaiyan, Mina Mirian, Afsaneh Lavasanifar

Abstract


Background and purpose: A simple, rapid, and sensitive reversed-phase high performance liquid chromatography (RP-HPLC) method based on liquid-liquid extraction was developed and validated for determination of docetaxel (DTX) in plasma and homogenate tissues of tumor-bearing mice.

Experimental approach: Samples were spiked with celecoxib as the internal standard and separation                was achieved on a μ-Bondapak C18 HPLC column. The mobile phase consisted of a mixture of acetonitrile/water (40/60 v/v) at flow rate of 1.2 mL/min and the effluent was monitored at 230 nm.

Results: Calibration curves were linear over the concentration range of 0.1-10 µg/mL of DTX in plasma              and 0.25-50 µg/mL in tissue homogenates with acceptable precision and accuracy. The mean recoveries of the drug from plasma extraction was 94.6 ± 1.44% while those of tissue homogenates ranged from 73.5 ± 3.2 to 85.3 ± 2.8% depending on the type of tissues examined. DTX was stable in biological samples with                no evidence of degradation during 3 freeze-thaw cycles and two months of storage at -70 ± 15 °C.                      The developed HPLC method was applied to quantify DTX in the mouse plasma and tissues                              after intravenous administration of 7.5 mg equivalent DTX/kg dose of DTX-loaded folic acid-polyethylene glycol-heparin-tocopherol (FA-PEG-HEP-CA-TOC) micelle formulation to female Balb/c mice.

Conclusion: A simple, sensitive, rapid, accurate, and prudent RP-HPLC method was developed, validated, and applied for DTX determination in plasma and tissues.


Keywords


Celecoxib; Distribution; Docetaxel; HPLC; Pharmacokinetics; Tissue.

Full Text:

PDF

References


Engels FK, Mathot RA, Verweij J. Alternative drug formulations of docetaxel: A review. Anticancer Drugs. 2007;18(2):95-103.

Qin YY, Li H, Guo XJ, Ye XF, Wei X, Zhou YH, et al. Adjuvant chemotherapy, with or without taxanes, in early or operable breast cancer: a meta-analysis of 19 randomized trials with 30698 patients. PloS One. 2011;6(11):1-11.

Farokhzad OC, Langer R. Impact of nanotechnology on drug delivery. ACS Nano. 2009;3(1):16-20.

Yang Y, Pan D, Luo K, Li L, Gu Z. Biodegradable and amphiphilic block copolymer-doxorubicin conjugate as polymeric nanoscale drug delivery vehicle for breast cancer therapy. Biomaterials. 2013;34(33):8430-8443.

Liu Y, Li K, Liu B, Feng SS. A strategy for precision engineering of nanoparticles of biodegradable copolymers for quantitative control of targeted drug delivery. Biomaterials. 2010;31(35):9145-9155.

Taymouri S, Varshosaz J, Javanmard SH, Hassanzadeh F. Development of a rapid and precise reversed-phase high-performance liquid chromatography method for analysis of docetaxel in rat plasma: application in single-dose pharmacokinetic studies of folate-targeted micelles containing docetaxel. Adv Biomed Res. 2018; 7:76-95.

Emami J, Kazemi M, Hasanzadeh F, Minaiyan M, Mirian M, Lavasanifar A. Novel pH-triggered biocompatible polymeric micelles based on heparin-α-tocopherol conjugate for intracellular delivery of docetaxel in breast cancer. Pharm Dev Technol. 2020;1:1-18.

Kuppens IE, Maanen MJ, Rosing H, Schellens JH, Beijnen JH. Quantitative analysis of docetaxel in human plasma using liquid chromatography coupled with tandem mass spectrometry. Biomed Chromatogr. 2005;19(5):355-361.

Hou W, Watters JW, Mcleod HL. Simple and rapid docetaxel assay in plasma by protein precipitation and high-performance liquid chromatography-tandem mass spectrometry. J Chromatogr B Analyt Technol Biomed Life Sci. 2004;804(2):263-267.

Parise RA, Ramanathan RK, Zamboni WC, Egorin MJ. Sensitive liquid chromatography-mass spectrometry assay for quantitation of docetaxel and paclitaxel in human plasma. J Chromatogr B Analyt Technol Biomed Life Sci. 2003;783(1):231-236.

Garg MB, Ackland SP. Simple and sensitive high-performance liquid chromatography method for the determination of docetaxel in human plasma or urine. J Chromatogr B Biomed Sci Appl. 2000;748(2):383-388.

Andersen A, Warren DJ, Brunsvig PF, Aamdal S, Kristensen GB, Olsen H. High sensitivity assays for docetaxel and paclitaxel in plasma using solid-phase extraction and high-performance liquid chromatography with UV detection. BMC Clin Pharmacol. 2006;6:2-11.

Rouini MR, Lotfolahi A, Stewart DJ, Molepo JM, Shirazi FH, Vergniol JC, et al. A rapid reversed phase high performance liquid chromatographic method for the determination of docetaxel (Taxotere) in human plasma using a column switching technique. J Pharm Biomed Anal. 1998;17(8);1243-1247.

Loos WJ, Verweij J, Nooter K, Stoter G, Sparreboom A. Sensitive determination of docetaxel in human plasma by liquid-liquid extraction and reversed-phase high-performance liquid chromatography. J Chromatogr B Biomed Sci Appl. 1997;693(2):437-341.

Ciccolini J, Catalin J, Blachon MF, Durand A. Rapid high-performance liquid chromatographic determination of docetaxel (Taxotere) in plasma using liquid-liquid extraction. J Chromatogr B Biomed Sci Appl. 2001;759(2):299-306.

Lopez LZ, Pastor AA, Beitia JMA, Velilla JA, Deiro JG. Determination of docetaxel and paclitaxel in human plasma by high-performance liquid chromatography: validation and application to clinical pharmacokinetic studies. Ther Drug Monit. 2006;28(2):199-205.

Zhao X, Zhao Y, Geng L, Li X, Wang X, Liu Z, et al. Pharmacokinetics and tissue distribution of docetaxel by liquid chromatography-mass spectrometry: evaluation of folate receptor-targeting amphiphilic copolymer modified nanostructured lipid carrier. J Chromatogr B Analyt Technol Biomed Life Sci. 2011;879(31):3721-3727.

Luo LH, Zheng PJ, Nie H, Chen YC, Tong D, Chen J, et al. Pharmacokinetics and tissue distribution of docetaxel liposome mediated by a novel galactosylated cholesterol derivatives synthesized by lipase-catalyzed esterification in non-aqueous phase. Drug Deliv. 2016;23(4):1282-1290.

Zhao L, Wei YM, Zhong XD, Liang Y, Zhang XM, Li W, et al. PK and tissue distribution of docetaxel in rabbits after i.v. administration of liposomal and injectable formulations. J Pharmaceut Biomed. 2009;49(4):989-996.

Emami J, Ghassami N, Talari R. A rapid and sensitive modified HPLC method for determination of diclofenac in human plasma and its application in pharmacokinetic studies. DARU. 2007;15(3);132-138.

Emami J, Rezazadeh M. Rapid, sensitive, and validated HPLC method for analysis of metronidazole and tinidazole under identical chromatographic conditions with UV detection and liquid-liquid extraction: application in bioequivalence studies. Acta Chromatogr. 2013;25:111-125.

Emami J, Ghassami N, Ahmadi F. Development and validation of a new HPLC method for determination of lamotrigine and related compounds in tablet formulations. J Pharm Biomed Anal. 2006;40(4):999-1005.

Rezazadeh M, Emami J, Mostafavi A, Rostami M, Hassanzadeh F, Sadeghi H, et al. A rapid and sensitive HPLC method for quantitation of paclitaxel in biological samples using liquid-liquid extraction and UV detection: application to pharmacokinetics and tissues distribution study of paclitaxel loaded targeted polymeric micelles in tumor bearing mice. J Pharm Pharm Sci. 2015;18(5):647-660.

Mozumder ZI, Nath LK. A high performance liquid chromatographic method for estimation of docetaxel in solid lipid nanoparticles. Int J Innov Pharm. 2015;3(8):1058-1065.

Kharkar P, Talkar S, Patravale V. A rapid and sensitive bio analytical RP-HPLC method for detection of docetaxel: development and validation. Indian J Pharm Educ. 2017;51(4):729-734.

Kim DW, Yousaf AM, Li DX, Kim JO, Yong CS, Cho KH, et al. Development of RP-HPLC method for simultaneous determination of docetaxel and curcumin in rat plasma: validation and stability. Asian J Pharm Sci. 2017;12(1):105-113.

Lee SW, Yun MH, Jeong SW, In CH, Kim JY, Seo MH, et al. Development of docetaxel-loaded intravenous formulation, Nanoxel-PM using polymer-based delivery system. J Control Release. 2011;155(2):262-271.

Garrec GL, Gori S, Luo L, Lessard D, Smith DC, Yessine MA, et al. Poly(N-vinylpyrrolidone)-block-poly (D,L-lactide) as a new polymeric solubilizer for hydrophobic anticancer drugs: in vitro and in vivo evaluation. J Control Release. 2004;99(1):83-101.

Cho HJ, Park JW, Yoon IS, Kim DD. Surface-modified solid lipid nanoparticles for oral delivery of docetaxel: enhanced intestinal absorption and lymphatic uptake. Int J Nanomedicine. 2014;9:495-504.

Vergniol JC, Bruno R, Montay G, Frydman A. Determination of Taxotere in human plasma by a semi-automated high-performance liquid chromatographic method. J Chromatogr. 1992;582(1-2):273-278.

Zhang H, Li RY, Lu X, Mou ZZ, Lin GM. Docetaxel-loaded liposomes: preparation, pH sensitivity, pharmacokinetics, and tissue distribution. J Zhejiang Univ Sci B. 2012;13(12):981-989.

Wang L, Liu Z, Liu D, Liu C, Juan Z, Zhang N. Docetaxel-loaded-lipid-based-nanosuspensions (DTX-LNS): preparation, pharmacokinetics, tissue distribution and antitumor activity. Int J Pharm. 2011;413(1-2):194-201.


Refbacks

  • There are currently no refbacks.


Creative Commons LicenseThis work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License which allows users to read, copy, distribute and make derivative works for non-commercial purposes from the material, as long as the author of the original work is cited properly.